These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 1599962)
1. Virulence associated proteins of Brucella abortus identified by paired two-dimensional gel electrophoretic comparisons of virulent, vaccine and LPS deficient strains. Sowa BA; Kelly KA; Ficht TA; Adams LG Appl Theor Electrophor; 1992; 3(1):33-40. PubMed ID: 1599962 [TBL] [Abstract][Full Text] [Related]
2. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants. Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice. Mukherjee F; Jain J; Grilló MJ; Blasco JM; Nair M Biologicals; 2005 Sep; 33(3):153-60. PubMed ID: 16081301 [TBL] [Abstract][Full Text] [Related]
4. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996 [TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Connolly JP; Comerci D; Alefantis TG; Walz A; Quan M; Chafin R; Grewal P; Mujer CV; Ugalde RA; DelVecchio VG Proteomics; 2006 Jul; 6(13):3767-80. PubMed ID: 16739129 [TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798 [TBL] [Abstract][Full Text] [Related]
8. Application of pulsed-field gel electrophoresis for differentiation of vaccine strain RB51 from field isolates of Brucella abortus from cattle, bison, and elk. Jensen AE; Cheville NF; Ewalt DR; Payeur JB; Thoen CO Am J Vet Res; 1995 Mar; 56(3):308-12. PubMed ID: 7771697 [TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking study of a RB51 B. abortus vaccinal strain isolated from cow milk. Arellano-Reynoso B; Díaz-Aparicio E; Leal-Hernández M; Hernández L; Gorvel JP Vet Microbiol; 2004 Mar; 98(3-4):307-12. PubMed ID: 15036539 [TBL] [Abstract][Full Text] [Related]
10. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Fernandez-Prada CM; Nikolich M; Vemulapalli R; Sriranganathan N; Boyle SM; Schurig GG; Hadfield TL; Hoover DL Infect Immun; 2001 Jul; 69(7):4407-16. PubMed ID: 11401980 [TBL] [Abstract][Full Text] [Related]
11. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409 [TBL] [Abstract][Full Text] [Related]
13. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines. Grilló MJ; Bosseray N; Blasco JM Biologicals; 2000 Jun; 28(2):119-27. PubMed ID: 10885618 [TBL] [Abstract][Full Text] [Related]
14. Extensive cell envelope modulation is associated with virulence in Brucella abortus. Lamontagne J; Butler H; Chaves-Olarte E; Hunter J; Schirm M; Paquet C; Tian M; Kearney P; Hamaidi L; Chelsky D; Moriyón I; Moreno E; Paramithiotis E J Proteome Res; 2007 Apr; 6(4):1519-29. PubMed ID: 17343405 [TBL] [Abstract][Full Text] [Related]
15. Identification of a virulence factor for Brucella abortus infection in BALB/c mice. Pugh GW; Tabatabai LB; Bricker BJ; Mayfield JE; Phillips M; McDonald TJ; Zehr ES Am J Vet Res; 1989 Jun; 50(6):887-92. PubMed ID: 2504086 [TBL] [Abstract][Full Text] [Related]
16. Effects of partial deletion of the wzm and wzt genes on lipopolysaccharide synthesis and virulence of Brucella abortus S19. Wang X; Wang L; Lu T; Yang Y; Chen S; Zhang R; Lang X; Yan G; Qian J; Wang X; Meng L; Wang X Mol Med Rep; 2014 Jun; 9(6):2521-7. PubMed ID: 24718931 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting. Teixeira-Gomes AP; Cloeckaert A; Bézard G; Bowden RA; Dubray G; Zygmunt MS Electrophoresis; 1997 Aug; 18(8):1491-7. PubMed ID: 9298663 [TBL] [Abstract][Full Text] [Related]
18. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382 [TBL] [Abstract][Full Text] [Related]
19. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Moriyón I; Grilló MJ; Monreal D; González D; Marín C; López-Goñi I; Mainar-Jaime RC; Moreno E; Blasco JM Vet Res; 2004; 35(1):1-38. PubMed ID: 15099501 [TBL] [Abstract][Full Text] [Related]
20. Differential composition of culture supernatants from wild-type Brucella abortus and its isogenic virB mutants. Delpino MV; Comerci DJ; Wagner MA; Eschenbrenner M; Mujer CV; Ugalde RA; Fossati CA; Baldi PC; Delvecchio VG Arch Microbiol; 2009 Jul; 191(7):571-81. PubMed ID: 19436993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]